Gore S M, Bird A G, Burns S, Ross A J, Goldberg D
MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK.
Int J STD AIDS. 1997 Mar;8(3):166-75. doi: 10.1258/0956462971919831.
434 male and 145 female prisoners were available to participate in cross-sectional, voluntary anonymous HIV surveillance (using saliva samples) with linked self-completion questionnaire at HMP (Her Majesty's Prison) Perth on 17 May and at HMP Cornton Vale on 18 May 1995. Three hundred and four men (70%) and 136 women (94%) completed a risk-factor questionnaire and 304 and 135 samples were received for HIV antibody testing. Two hundred and eighty-two and 132 questionnaires passed logical checks. Six saliva samples from Perth (all injectors) out of 304 and none from Cornton Vale out of 134 tested were HIV antibody positive. Four were presumptively from known HIV-infected male inmates; the other 2 were local men, under 26 years, who began injecting in 1989-91, and both reported having had a recent HIV test. Overall HIV prevalence was estimated at 2% compared to a known prevalence of 1.4% (6/434), giving a 1.5 ratio of overall: disclosed HIV prevalence at HMP Perth. HIV prevalence was estimated at 7% (6/82) for injector-participants and 14% (5/35) for local injector participants. At Cornton Vale, where both known HIV-infected inmates abstained, overall and disclosed HIV prevalence, were equal at 1.4%. At Perth Prison, 29% of prisoners had injected drugs (82/278); 85% of injector-inmates reported having injected inside (some prison and 31% (25/80) had started to inject while inside, 7 during their present sentence. Of all 21 injector-inmates who first injected after 1991, 10 had started to inject inside, including one of 69 male inmates who had never been inside before. The corresponding figures for Cornton Vale, where 46% of inmates were injectors (58/132), were that 57% of injector-inmates had injected inside (32/56) but only one woman, for whom this was not her first sentence, had started to inject inside. Twenty-eight per cent of male prisoners (78/277) and 57% of male injector-inmates (47/82) had had a personal HIV test since January 1993, as had 35% of female prisoners (43/124) and 57% of female injector-inmates (30/53). A much higher proportion of Glasgow's female prisoners (64%: 38/60) were injectors than of women prisoners from the Edinburgh, Dundee and Fife area (21%: 5/26) or from elsewhere (34%: 15/45). Rape was reported by 23% of women (30/130). Women who had been raped had a more polarized distribution of male sexual partners (none to 2 plus) in the year before sentencing than other women and were more likely to report anal sex (11/30 vs 11/100, P < 0.001). Prostitution had been engaged in by 19% of female injector-inmates (11/57) and was acknowledged by one other woman. However, only 5% of women (6/130) reported ever having been treated for an STD.
1995年5月17日,434名男性和145名女性囚犯参与了在珀斯皇家监狱(HMP Perth)开展的横断面自愿匿名艾滋病毒监测(使用唾液样本),并填写了相关自填式问卷;5月18日,科恩顿韦尔女子监狱(HMP Cornton Vale)也进行了同样的监测。304名男性(70%)和136名女性(94%)完成了风险因素问卷,共收到304份男性样本和135份女性样本用于艾滋病毒抗体检测。282份男性问卷和132份女性问卷通过了逻辑检查。珀斯监狱的304份样本中有6份(均为注射吸毒者)唾液样本艾滋病毒抗体呈阳性,科恩顿韦尔女子监狱的134份样本中无一例阳性。其中4例推测来自已知感染艾滋病毒的男性囚犯;另外2例是当地男性,年龄在26岁以下,于1989 - 1991年开始注射吸毒,两人均报告最近进行过艾滋病毒检测。总体艾滋病毒感染率估计为2%,而已知感染率为1.4%(6/434),珀斯皇家监狱总体感染率与已披露感染率之比为1.5。注射吸毒参与者的艾滋病毒感染率估计为7%(6/82),当地注射吸毒参与者的感染率为14%(5/35)。在科恩顿韦尔女子监狱,已知感染艾滋病毒的囚犯均未参与,总体和已披露的艾滋病毒感染率均为1.4%。在珀斯监狱,29%的囚犯曾注射过毒品(82/278);85%的注射吸毒囚犯报告在监狱内注射过(部分在监狱内,31%(25/80)在服刑期间开始注射,7人在当前刑期内开始注射。在1991年后首次注射毒品的21名注射吸毒囚犯中,有10人在监狱内开始注射,其中包括69名从未入狱过的男性囚犯中的1人。科恩顿韦尔女子监狱的相应数据为,46%的囚犯是注射吸毒者(58/132),5